Innovation and Market Structure in the Dynamics of the Pharmaceutical Industry and Biotechnology: towards a History Friendly Model

نویسندگان

  • Franco Malerba
  • Luigi Orsenigo
چکیده

We thank Luca Berga, Christian Garavaglia and Nicola Lacetera for their invaluable contribution to the development of the model. We thank the Merck Foundation for its support through the Epris (European Pharmaceutical Regulation and Innovation Systems) Project. 2

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Marketing Innovation and Brand Performance of Superior Pharmaceutical Companies in 2017: A Descriptive Study

Background and Objectives: Lack of attention to marketing innovation for achieving competitive advantage leads to pharmaceutical brands performance decline. In this regard, the purpose of the present research was to determine the relationship between marketing innovation and market performance of pharmaceutical brands. Materials and Methods: In this descriptive study, statistical population in...

متن کامل

Proposing Dynamic Model of Functional Interactions of IoT Technological Innovation System by Using System Dynamics and Fuzzy DEMATEL

One of the emerging technologies, which is expected to have tremendous effects on community development, is the Internet of Things technology. Given the prospects for this technology and the countrychr('39')s efforts to its development, policymaking for this technology is very crucial. The technological innovation system is one of the most important dynamic approaches in the field of modern tec...

متن کامل

Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry

Abstract Background and scope: The current situation in Iran suggests a good basis for advancement in biotechnology industries because the patents for many hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies without patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present researc...

متن کامل

A Dynamic Model for Promotion of Iranian Pharmaceutical and Biological Enterprises

  The purpose of this paper is to make explicit how companies in pharmaceutical sector can ensure their position in different markets by relying on a sustainable competitive advantages resulted from using a good defined marketing model. Various factors are highlighted including high research and development roles and costs, hard government regulation in frame of GMP standard, market analysis to...

متن کامل

Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)

Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowled...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2001